Injective has been rallying for months and has defied the bear market, which has drained most other crypto assets. Due to its super bullish fundamentals, it has stolen the limelight and will probably continue to do so.
Its uptrend has been very healthy so far, and we can see that through INJBTC. INJ has been doing very well relative to BTC, and both INJUSD and INJBTC look clean. What I mean is that technically they look solid, as they have had several corrections and consolidations. Therefore the current trend looks sustainable.
The two key areas I think INJUSD is targeting next are 10.3$ and 14.5$. Those two areas have a lot of liquidity, given that triple/quadruple tops have formed there. I expect the market to hit those targets in the next few months. Taking profits in those zones makes sense only in the short term, simply to add more in case the market corrects once it gets there.
Its uptrend has been very healthy so far, and we can see that through INJBTC. INJ has been doing very well relative to BTC, and both INJUSD and INJBTC look clean. What I mean is that technically they look solid, as they have had several corrections and consolidations. Therefore the current trend looks sustainable.
The two key areas I think INJUSD is targeting next are 10.3$ and 14.5$. Those two areas have a lot of liquidity, given that triple/quadruple tops have formed there. I expect the market to hit those targets in the next few months. Taking profits in those zones makes sense only in the short term, simply to add more in case the market corrects once it gets there.
Отказ от ответственности
Информация и публикации не предназначены для предоставления и не являются финансовыми, инвестиционными, торговыми или другими видами советов или рекомендаций, предоставленных или одобренных TradingView. Подробнее читайте в Условиях использования.
Отказ от ответственности
Информация и публикации не предназначены для предоставления и не являются финансовыми, инвестиционными, торговыми или другими видами советов или рекомендаций, предоставленных или одобренных TradingView. Подробнее читайте в Условиях использования.